Montalbano John S.

Average Profitability
<0.0001%
Insider Buys Quantity
8
Insider Buys Sum
$1.21M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Montalbano John S.

According to the SEC Form 4 filings, Montalbano John S., being in a position of

  1. director at AbCellera Biologics Inc.,
    оver the last 12 months, has bought 85000 shares for $198,068, and sold 0 shares,
    over all time since 2020-12-15, has bought 176000 shares for $1.21M, and sold 0 shares.

The largest purchase of all time was on 2020-12-15 and amounted to 25000 shares of AbCellera Biologics Inc. for $500,000.

Biography of Montalbano John S.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Prismo
Buys
 $198,0682100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

Prismo
Prismo
2025-03-10PurchaseAbCellera Biologics Inc.
ABCL
director
25,000
0.0088%
$2.30$57,500+7.95%
2025-03-06PurchaseAbCellera Biologics Inc.
ABCL
director
60,000
0.0198%
$2.34$140,568-1.89%
2023-11-08PurchaseAbCellera Biologics Inc.
ABCL
director
10,000
0.0037%
$4.46$44,600-7.89%
2023-11-06PurchaseAbCellera Biologics Inc.
ABCL
director
20,000
0.0071%
$4.64$92,800-13.76%
2022-03-04PurchaseAbCellera Biologics Inc.
ABCL
director
10,000
0.0035%
$8.54$85,400+20.22%
2022-03-01PurchaseAbCellera Biologics Inc.
ABCL
director
20,000
0.0071%
$9.05$181,000+13.38%
2021-08-16PurchaseAbCellera Biologics Inc.
ABCL
director
6,000
0.0021%
$17.23$103,380-39.72%
2020-12-15PurchaseAbCellera Biologics Inc.
ABCL
director
25,000
0.0067%
$20.00$500,000-51.21%
Total: 8
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Sells over the last 12 months, USD